Intra-arterial Delivery of Tislelizumab plus Transarterial Chemoembolization for Rectal Cancer: A Novel Regimen to Achieve Sphincter Preservation and Prevent Anastomotic Leakage

Wenjun Meng; Yueting Zhu; Jialing Wang; Jiadi Gan; Jiyan Liu; Dong Wang; Weimin Li; Chunxue Li

doi:10.1002/mco2.70456

MedComm ›› 2025, Vol. 6 ›› Issue (11) : e70456 DOI: 10.1002/mco2.70456

LETTER

Intra-arterial Delivery of Tislelizumab plus Transarterial Chemoembolization for Rectal Cancer: A Novel Regimen to Achieve Sphincter Preservation and Prevent Anastomotic Leakage

Author information +

History +

PDF

Cite this article

Download citation ▾

Wenjun Meng, Yueting Zhu, Jialing Wang, Jiadi Gan, Jiyan Liu, Dong Wang, Weimin Li, Chunxue Li. Intra-arterial Delivery of Tislelizumab plus Transarterial Chemoembolization for Rectal Cancer: A Novel Regimen to Achieve Sphincter Preservation and Prevent Anastomotic Leakage. MedComm, 2025, 6(11): e70456 DOI:10.1002/mco2.70456

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	D. Li, X. Xiong, P. Diao, et al., “The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer,” Current Treatment Options in Oncology 26, no. 2 (2025): 84-91.

[2]	G. Sun, Z. Lou, H. Zhang, et al., “Retrospective Study of the Functional and Oncological Outcomes of Conformal Sphincter Preservation Operation in the Treatment of Very Low Rectal Cancer,” Techniques in Coloproctology 24 (2020): 1025-1034.

[3]	J. M. Michael-Robinson, A. Biemer-Hüttmann, D. M. Purdie, et al., “Tumour Infiltrating Lymphocytes and Apoptosis Are Independent Features in Colorectal Cancer Stratified According to Microsatellite Instability Status,” Gut 48, no. 3 (2001): 360-366.

[4]	D. T. Le, J. N. Durham, K. N. Smith, et al., “Mismatch Repair Deficiency Predicts Response of Solid Tumors to PD-1 Blockade,” Science 357, no. 6349 (2017): 409-413.

[5]	F. Xia, Y. Wang, H. Wang, et al., “Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH),” Journal of Clinical Oncology (2024): Jco2302261.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.